GERON CORPORATION
Last · NasdaqGS$1.22-0.005 (-0.41%)stale · yahoo · 55h ago
Vol 3.98M ≈ 4.86M
MA10MA20MA50
Market cap$783.82M642.5M sh
P/E · TTM-11.1fwd 30.5 · eps -0.11 · loss
Beta0.61vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.04$2.01
Volume4.0Msession
Issuer
Legal nameGERON CORPORATION
HQUnited States (US)
ListingUS GERN
ISINUS3741631036
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0000886744
CIK0000886744
Websitewww.geron.com
Employees258
AddressGeron Corp. 919 East Hillsdale Boulevard 94404, Foster City +650 473 7700
| Revenue | $109.3M |
|---|---|
| Operating income | $-12.3M |
| Net income | $-20.3M |
| Operating margin | -11.3% |
| Net margin | -18.6% |
| Return on equity | -9.3% |
| Period | 2026 |
Loading chart…
Upcoming earnings
WED.4NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.01
Est. revenue
60.7M
Earnings transcripts
Press & signals
- GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans